Skip to content
Back to signals

Chamath Palihapitiya · Aug 23, 09:29 PM UTC

Bitcoin’s Best Week Since 2024

xyz:MRNABUYHIGH confidenceUpdated Aug 27, 06:02 AM UTC

Historical operation · Retained

“3) Moderna Surges 177% on Positive Phase 3 Cancer Vaccine Results”

Quoted source · Chamath Palihapitiya · 5 source segments

  • [1] Chamath Palihapitiya
  • [2] Chamath Palihapitiya
  • [3] Chamath Palihapitiya
  • [4] Chamath Palihapitiya
  • [5] Chamath Palihapitiya
Read original source

Model assessment

Segments 13-17 report that Moderna and Merck's personalized cancer treatment succeeded in a Phase 3 trial, with patients receiving the treatment plus Keytruda going longer without cancer recurrence or spread. Moderna shares closed 177% higher, indicating a strong positive market reaction. This represents a material positive catalyst for Moderna.

5 exact transcript citations

Current publication unavailable.

This publication could not be verified. Refresh to try again.

Refresh